PT Suparma Tbk (IDX:SPMA)

Total Valuation

PT Suparma Tbk has a market cap or net worth of IDR 933.61 billion. The enterprise value is 1.44 trillion.

Market Cap	933.61B
Enterprise Value	1.44T

Important Dates

The next estimated earnings date is Wednesday, October 29, 2025.

Earnings Date	Oct 29, 2025
Ex-Dividend Date	n/a

Share Statistics

PT Suparma Tbk has 3.15 billion shares outstanding.

Current Share Class	3.15B
Shares Outstanding	3.15B
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	81.58%
Owned by Institutions (%)	0.02%
Float	n/a

Valuation Ratios

The trailing PE ratio is 8.57.

PE Ratio	8.57
Forward PE	n/a
PS Ratio	0.34
PB Ratio	0.38
P/TBV Ratio	0.38
P/FCF Ratio	1.59
P/OCF Ratio	1.51
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 5.22, with an EV/FCF ratio of 2.44.

EV / Earnings	13.19
EV / Sales	0.52
EV / EBITDA	5.22
EV / EBIT	9.25
EV / FCF	2.44

Financial Position

The company has a current ratio of 2.37, with a Debt / Equity ratio of 0.27.

Current Ratio	2.37
Quick Ratio	0.59
Debt / Equity	0.27
Debt / EBITDA	2.43
Debt / FCF	1.14
Interest Coverage	4.67

Financial Efficiency

Return on equity (ROE) is 4.53% and return on invested capital (ROIC) is 3.17%.

Return on Equity (ROE)	4.53%
Return on Assets (ROA)	2.81%
Return on Invested Capital (ROIC)	3.17%
Return on Capital Employed (ROCE)	5.38%
Revenue Per Employee	3.33B
Profits Per Employee	132.15M
Employee Count	808
Asset Turnover	0.79
Inventory Turnover	2.41

Taxes

In the past 12 months, PT Suparma Tbk has paid 30.81 billion in taxes.

Income Tax	30.81B
Effective Tax Rate	22.06%

Stock Price Statistics

The stock price has decreased by -4.58% in the last 52 weeks. The beta is 0.65, so PT Suparma Tbk's price volatility has been lower than the market average.

Beta (5Y)	0.65
52-Week Price Change	-4.58%
50-Day Moving Average	269.52
200-Day Moving Average	280.89
Relative Strength Index (RSI)	65.55
Average Volume (20 Days)	565,025

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, PT Suparma Tbk had revenue of IDR 2.74 trillion and earned 108.89 billion in profits. Earnings per share was 34.52.

Revenue	2.74T
Gross Profit	382.07B
Operating Income	155.36B
Pretax Income	139.71B
Net Income	108.89B
EBITDA	269.49B
EBIT	155.36B
Earnings Per Share (EPS)	34.52

Balance Sheet

The company has 165.45 billion in cash and 668.53 billion in debt, giving a net cash position of -503.07 billion or -159.50 per share.

Cash & Cash Equivalents	165.45B
Total Debt	668.53B
Net Cash	-503.07B
Net Cash Per Share	-159.50
Equity (Book Value)	2.44T
Book Value Per Share	772.88
Working Capital	848.19B

Cash Flow

In the last 12 months, operating cash flow was 618.34 billion and capital expenditures -30.51 billion, giving a free cash flow of 587.83 billion.

Operating Cash Flow	618.34B
Capital Expenditures	-30.51B
Free Cash Flow	587.83B
FCF Per Share	186.37

Margins

Gross margin is 13.93%, with operating and profit margins of 5.67% and 3.97%.

Gross Margin	13.93%
Operating Margin	5.67%
Pretax Margin	5.09%
Profit Margin	3.97%
EBITDA Margin	9.83%
EBIT Margin	5.67%
FCF Margin	21.44%

Dividends & Yields

This stock pays an annual dividend of 12.00, which amounts to a dividend yield of 4.14%.

Dividend Per Share	12.00
Dividend Yield	4.14%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	4
Payout Ratio	34.68%
Buyback Yield	n/a
Shareholder Yield	4.14%
Earnings Yield	11.66%
FCF Yield	62.96%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on June 15, 2022. It was a forward split with a ratio of 1.13.

Last Split Date	Jun 15, 2022
Split Type	Forward
Split Ratio	1.13

Scores

PT Suparma Tbk has an Altman Z-Score of 2.2 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.2
Piotroski F-Score	6